Cheryl Riel

Director, Nonclinical Writing and Document Management at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Cheryl Riel's Colleagues at Alnylam Pharmaceuticals
Sandeep Duttagupta

Vice President, Global Pricing & Market Access

Contact Sandeep Duttagupta

Kimberly Harding

Senior Associate Scientist- EDEV Histopathology

Contact Kimberly Harding

Rui Xiong

Principal Scientist, Investigative Toxicology

Contact Rui Xiong

Shridhar Patel

Senior Manager, Statistical Programming

Contact Shridhar Patel

Geoffrey Cole

Associate Director, Immunoassay Development

Contact Geoffrey Cole

View All Cheryl Riel's Colleagues
Cheryl Riel's Contact Details
HQ
(617) 551-8200
Location
316 Huntington Avenue,Boston,Massachusetts,02115,United States
Company
Alnylam Pharmaceuticals
Cheryl Riel's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Cheryl Riel
Cheryl Riel currently works for Alnylam Pharmaceuticals.
Cheryl Riel's role at Alnylam Pharmaceuticals is Director, Nonclinical Writing and Document Management.
Cheryl Riel's email address is ***@alnylam.com. To view Cheryl Riel's full email address, please signup to ConnectPlex.
Cheryl Riel works in the SaaS industry.
Cheryl Riel's colleagues at Alnylam Pharmaceuticals are Babak Basiri, Sandeep Duttagupta, Kimberly Harding, Fabienne Costa, Rui Xiong, Shridhar Patel, Geoffrey Cole and others.
Cheryl Riel's phone number is (617) 551-8200
See more information about Cheryl Riel